Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Takei

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Diagnostic Pathology|November 17, 2016
Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological studyRyuji Ohashi, Ayako Hayama, Keiko Yanagihara, et al.
Clinical and Experimental Nephrology|April 7, 2004
Membranous nephropathy complicated by renal cell carcinomaYuko Fujita, Tetsuya Kashiwagi, Hiroyuki Takei, et al.
Biology|July 2, 2021
Breast Cancer Detection from a Urine Sample by Dog Sniffing: A Preliminary Study for the Development of a New Screening Device, and a Literature ReviewShoko Kure, Shinya Iida, Marina Yamada, et al.
Breast Cancer Research and Treatment|January 12, 2012
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)Hiroyuki Takei, Shozo Ohsumi, Kojiro Shimozuma, et al.
Oncology Reports|April 6, 2006
The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cellsYoshio Horii, Hiroyuki Takei, Yukio Koibuchi, et al.
Experimental and Therapeutic Medicine|September 21, 2012
Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosisYawara Omoto, Masafumi Kurosumi, Yasuo Hozumi, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|December 25, 2013
[The survey of radiation dose in radiofrequency catheter ablation]Takao Kanzaki, Masashi Andou, Hiroki Okada, et al.
Pathology, Research and Practice|November 14, 2017
Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotypeRyuji Ohashi, Keiko Yanagihara, Shigeki Namimatsu, et al.
International Journal of Clinical Oncology|January 15, 2013
A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06)Hideki Takeuchi, Hiroyuki Takei, Kazushige Futsuhara, et al.
Cancer Diagnosis & Prognosis|March 4, 2026
Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational StudyTakaaki Fujii, Kei Ichiba, Mayu Aoki, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Diagnostic Pathology|November 17, 2016
Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological studyRyuji Ohashi, Ayako Hayama, Keiko Yanagihara, et al.
Clinical and Experimental Nephrology|April 7, 2004
Membranous nephropathy complicated by renal cell carcinomaYuko Fujita, Tetsuya Kashiwagi, Hiroyuki Takei, et al.
Biology|July 2, 2021
Breast Cancer Detection from a Urine Sample by Dog Sniffing: A Preliminary Study for the Development of a New Screening Device, and a Literature ReviewShoko Kure, Shinya Iida, Marina Yamada, et al.
Breast Cancer Research and Treatment|January 12, 2012
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)Hiroyuki Takei, Shozo Ohsumi, Kojiro Shimozuma, et al.
Oncology Reports|April 6, 2006
The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cellsYoshio Horii, Hiroyuki Takei, Yukio Koibuchi, et al.
Experimental and Therapeutic Medicine|September 21, 2012
Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosisYawara Omoto, Masafumi Kurosumi, Yasuo Hozumi, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|December 25, 2013
[The survey of radiation dose in radiofrequency catheter ablation]Takao Kanzaki, Masashi Andou, Hiroki Okada, et al.
Pathology, Research and Practice|November 14, 2017
Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotypeRyuji Ohashi, Keiko Yanagihara, Shigeki Namimatsu, et al.
International Journal of Clinical Oncology|January 15, 2013
A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06)Hideki Takeuchi, Hiroyuki Takei, Kazushige Futsuhara, et al.
Cancer Diagnosis & Prognosis|March 4, 2026
Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational StudyTakaaki Fujii, Kei Ichiba, Mayu Aoki, et al.
Pageof 18